by Abigail Klein Leichman
While it’s not so simple to find cancerous cells before they have multiplied enough to be noticeable, it might not be long before healthcare workers can start stocking an American-Israeli bio-tech company’s diagnostic kit that can detect increased risk for breast cancer. Earlier this summer, a subsidiary of Ramat Gan-based Micromedic Technologies submitted an application to the US Food and Drug Administration for approval to begin testing the kit’s effectiveness in clinical use. Already, clinical studies at Hadassah Medical Center in Jerusalem show that the kit achieves a nearly perfect rate of detection sensitivity. http://www.israel21c.org/201012078564/health/fighting-cancer-with-early-detection